September 21

0 comments

Peter Laird: Epigenetics, DNA Methylation, and Arrays

By heheals

September 21, 2020




Peter Laird, PhD, discusses his studies of epigenetics and the role DNA methylation may play in contributing to cancer. Dr. Laird highlights the importance of better tools and being able to choose the right one for your research — from Illumina microarrays for quick work and a lot of samples http://www.illumina.com/techniques/microarrays.html to next-generation sequencing for understanding more detail about the whole genome http://www.illumina.com/technology/next-generation-sequencing.html.

Researcher: Peter Laird, PhD
Professor at the Center for Epigentics
The Van Andel Research Institute

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.

http://www.youtube.com/subscription_center?add_user=IlluminaInc

View related videos
Scott Weiss: Population Studies, Biobanks and Arrays‬

View related information
http://www.illumina.com/techniques/microarrays.html
http://www.illumina.com/technology/next-generation-sequencing.html

Subscribe to the Illumina video channel
http://www.youtube.com/subscription_center?add_user=IlluminaInc

source

heheals

About the author

Leave a Repl​​​​​y

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Never miss a good story!

 Subscribe to our newsletter to keep up with the latest trends!